Table 2.
Electrode | Biorecognition Element |
Biomarker | Technique | LOD | Working Range |
Sample | Response Time |
Year | Ref. |
---|---|---|---|---|---|---|---|---|---|
Gold | BP3 peptide | PCT | EIS | 12.5 ng/mL | 0.013–0.25 g/mL |
Buffer | / | 2017 | [65] |
Carbon screen printed | Antibody | PCT | Amperometric | 0.1 ng/mL | 0.5–1000 ng/mL | Human serum | <20 min | 2020 | [66] |
Gold | Antibody | PCT | Amperometric | 0.04 ng/mL | 0.1–20 ng/mL | Plasma | <20 min | 2020 | |
Carbon screen printed | Antibody | CRP | Amperometric | 0.80 g/mL | 2–100 g/mL | Plasma | 5 min | 2020 | [67] |
Carbon screen printed | Antibody | CRP | Amperometric | 0.058 g/mL | 1–100 g/mL | Plasma | 5 min | 2021 | [68] |
Glassy carbon electrode | Antibody | PCT | Amperometric | 0.011 pg/mL | 0.0001–100 ng/mL | Diluted serum | 50 min | 2022 | [69] |
Glassy carbon electrode | Antibody | PCT | DPV | 0.46 pg/mL | 0.001–100 ng/mL | Diluted human serum | / | 2021 | [70] |
Glassy carbon electrode | Antibody | PCT | DPV | 0.3 pg/mL | 1 pg/mL–100 ng/mL | Human serum | / | 2021 | [71] |
Gold interdigitated electrode | Antibody | PCT, CRP |
EIS | 10 ng/mL | 0.01–10 ng/mL |
Human Serum | <15 min | 2019 | [72] |
Gold electrode | Antibody | PCT, CRP |
Amperometric | 10 ng/mL | 0.01–10 ng/mL |
Clinical sample | <15 min | 2021 | [73] |
Gold electrode on microneedle | Antibody | IL-6 | DPV | / | 20–100 pg/mL | Human Serum spiked | 3 min | 2018 | [74] |
Gold interdigitated | Antibody | IL-3 | Capacitive | 3.0 pg/mL | 3.0–100 pg/mL | Human Serum spiked | / | 2021 | [75] |
Gold screen printed | Antibody | IL-3 | Chronoamperometry | 10 pg/mL | 10–104 pg/mL | Plasma/serum from clinical sample | <1 h | 2018 | [76] |
Gold | Antibody | IL-6, IL-8, IL-10, TRAIL, IP 10 | EIS | 0.1, 0.1, 1.0, 1.0, 1.0 pg/mL | 0.01–104, 0.1–5000, 0.1–103, 1.0–2103 pg/mL |
Plasma | 5 min | 2021 | [77] |
Disposable sensor cartridge with a gold-based array electrodes | Antibody | IL-6, IL-8, IL-10, TRAIL, IP 10 | Label-free non faradic impedence spetroscopy |
0.1, 0.1, 1.0, 1.0, 1.0 pg/mL | 0.01–104, 0.1–5000, 0.1–103, 1.0–2103 pg/mL |
Clinical samples | 5 min | 2022 | [78] |
Gold | RNA specific probe | 16S RNA from S. aureus, E coli, P aeruginosa, P. mirabilis |
Amperometry | 290 CFU/mL | / | Human blood | <1 h | 2017 | [79] |
Indium tin oxide coated glass | Conductive MIP | K. pneumoniae | DPV | 1.35 CFU/mL | 1.0–1.0105 CFU/mL | Spiked human urine | 3 min | 2022 | [80] |
Gold | CRISPR/Cas12a | DNA from E. coli, S. aureus |
EIS | 3.0 nM | 3 –18 nM | Buffer solution spiked clinical strains | 1 h | 2022 | [81] |
Abbreviations: EIS electrochemical impedance spectroscopy, DPV differential pulse voltammetry, MIP molecularly imprinted polymers.